share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Oosthuizen Johannes Jacobus

SEC announcement ·  Feb 5 16:04
Summary by Moomoo AI
On February 2, 2024, Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a series of transactions involving the company's common stock. Oosthuizen acquired a total of 20,937 shares through the exercise or conversion of derivative securities at prices ranging from $73.73 to $87.10. On the same day, he disposed of 18,959 shares in an open market sale at a price of $127.175 per share, resulting in a total market value of $2,411,110.82. Following these transactions, Oosthuizen's direct holdings in Merck & Co. amounted to 23,327.345 shares of common stock.
On February 2, 2024, Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a series of transactions involving the company's common stock. Oosthuizen acquired a total of 20,937 shares through the exercise or conversion of derivative securities at prices ranging from $73.73 to $87.10. On the same day, he disposed of 18,959 shares in an open market sale at a price of $127.175 per share, resulting in a total market value of $2,411,110.82. Following these transactions, Oosthuizen's direct holdings in Merck & Co. amounted to 23,327.345 shares of common stock.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more